Resilience and metacognitions as predictors of outcome in a randomized controlled treatment trial of generalized anxiety disorder

摘要

Background: This study aim was to explore resilience and metacognitions in the understanding of changes in patients with generalized anxiety disorder (GAD).Method: 57 patients were included in a randomized controlled treatment trial for GAD. The patients were randomized to three conditions, waiting list, cognitive behavioral therapy (CBT) and metacognitive therapy (MCT).Results: This study explored how resilience {Resilience Scale for Adults [1]) and metacognitions (MCQ-30; [2]) predict changes in GAD symptoms measured by e.g. PSWQ. To the best of our knowledge this is the first time these predictors are explored in such a context.Conclusions: Understanding how resilience factors and metacognitions predict the changes of GAD symptoms related to treatment may potentially give a new perspective to treatment related changes in GAD patients.